Phreesia, Inc. (NYSE:PHR) Shares Acquired by Greenhouse Funds LLLP

Greenhouse Funds LLLP grew its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 27.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,873,892 shares of the company's stock after purchasing an additional 626,579 shares during the period. Phreesia comprises about 3.0% of Greenhouse Funds LLLP's portfolio, making the stock its 18th biggest position. Greenhouse Funds LLLP owned about 4.94% of Phreesia worth $72,307,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Barclays PLC boosted its position in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after buying an additional 43,225 shares during the period. Geode Capital Management LLC boosted its holdings in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after purchasing an additional 55,934 shares during the period. Franklin Resources Inc. grew its stake in Phreesia by 3.0% during the 3rd quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock worth $31,495,000 after purchasing an additional 42,973 shares in the last quarter. Wesbanco Bank Inc. increased its holdings in Phreesia by 76.9% during the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock worth $1,157,000 after purchasing an additional 20,000 shares during the period. Finally, R Squared Ltd acquired a new stake in Phreesia in the 4th quarter valued at about $30,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

Phreesia Stock Performance

NYSE PHR traded up $0.14 during trading on Friday, reaching $24.73. The company's stock had a trading volume of 268,854 shares, compared to its average volume of 432,264. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of -16.82 and a beta of 0.82. The business's fifty day moving average price is $25.51 and its 200-day moving average price is $24.39. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.

Analysts Set New Price Targets

PHR has been the subject of a number of recent research reports. DA Davidson decreased their price target on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Piper Sandler reissued an "overweight" rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Citigroup upped their price objective on Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a research report on Friday, January 10th. KeyCorp decreased their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Finally, Needham & Company LLC reissued a "buy" rating and set a $29.00 price objective on shares of Phreesia in a report on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $31.33.

Insider Buying and Selling

In other news, insider Yvonne Hui sold 1,878 shares of the firm's stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $44,790.30. Following the completion of the sale, the insider now owns 28,449 shares in the company, valued at approximately $678,508.65. This trade represents a 6.19 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP David Linetsky sold 4,499 shares of Phreesia stock in a transaction dated Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total transaction of $106,761.27. Following the completion of the sale, the senior vice president now directly owns 217,239 shares in the company, valued at approximately $5,155,081.47. The trade was a 2.03 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 146,930 shares of company stock valued at $4,067,102 over the last quarter. 5.80% of the stock is currently owned by insiders.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.